Background. Traditional ABO blood group serology is based on the immun
oreactivity of antisera with the carbohydrate A, B and H antigens. Pro
gress in the molecular biology of the ABO system has recognized the mo
lecular basis of the red cell (RBC) antigens and has provided a geneti
c model for ABO polymorphism at the molecular level. Recently, this ge
netic model was tested in a large number of individuals. Materials and
Methods. In this study we applied DNA analysis to determine the frequ
ency of ABO genotypes in a group of blood donors for whom the ABO type
was known. Two hundred and fifty healthy Italian blood donors were an
alyzed using polymerase chain reaction (PCR) to amplify two different
regions of genomic DNA, each of which contained a different nucleotide
polymorphism. The amplified product was digested with 4 restriction e
nzymes that revealed differences among A, B and 0 individuals. To anal
yze the genes at polymorphic sites 261 and 703 we used the restriction
enzymes BstE II and Kpn I, and Hpa II and Alu I and compared the PCR
determined genotypes to serologically determined phenotypes. Results a
nti Conclusions. The results were consistent for all unrelated individ
uals; however, 2 of 100 individuals with the 0 phenotype carried one a
llele that differed from the proposed genetic model. This novel 0 alle
le, termed 0(2) by Yamamoto et al., was found in our series with a fre
quency of 1%. The blood group ABO genotype of 250 healthy Italian bloo
d donors was: 13 AA/A0(2), 37 A0(1), 11 BE, 39 B0(1), 50 AB, 98 0(1)0(
1) and 2 0(1)0(2). This method should be applicable not only in forens
ic medicine but also in immunohematology when serology fails.